‘Contracting out’ government functions for delivery by the private sector has become the standard way of doing things across all levels of government in Australia.
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
Since the WHO’s investigation earlier this year, several papers have come to the same conclusion regarding the likely origins of SARS-CoV-2. Yet progress is too slow.
While there are plausible explanations for why this occurs, we can’t be certain of the effect of temperature on SARS-CoV-2. Being indoors in poorly ventilated spaces plays a big role.
Another wave of COVID-19 in Russia is undermining public health and threatens economic recovery. But widespread mistrust of institutions will stymie the country’s efforts to move past the pandemic.
Nurses and healthcare workers will need more support in the longer term to deal with the considerable effect COVID-19 has had on mental health and wellbeing.
Anti-vaccine activists are using the side effect reporting system to spread fear and misinformation about the COVID-19 vaccines. But the database could also be used as a gauge for public concerns.
Governments cannot keep making unrealistic promises about easing restrictions at 70% and 80% adult vaccination, a plan that relied on optimistic scenarios in the first place.
Trials are under way to ascertain whether COVID vaccines are safe and effective for children under 12. In the meantime, it’s reassuring to note that generally, young kids cope OK with the virus.
A brief daily practice of mindfulness meditation not only contributes to a better mood, but it also helps protect against the negative mental health impact of news about COVID-19.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand